TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10080835

Group type: EXPERIMENTAL
Intervention: High dose BCG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose BCG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose BCG with IFN-alpha
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal control individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment arms (High dose BCG, Low dose BCG, Low dose BCG with IFN-alpha)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peripheral blood lymphocytes from cancer patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravesical treatment
Number of subjects: 0
Study: 7590403

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (50 mg zinc as 220 mg zinc sulphate daily for 4 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2073045

Group type: EXPERIMENTAL
Intervention: Propofol-Ketamine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Propofol-Fentanyl
Number of subjects: 10
Study: 7428446

Group type: EXPERIMENTAL
Intervention: Non-smoking periods
Number of subjects: 12

Group type: COMPARATOR
Intervention: Smoking cessation
Number of subjects: 12
Study: 31761416

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral superficial cervical plexus block with 10 ml of ropivacaine 0.5%
Number of subjects: 74

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 74
Study: 29771184

Group type: EXPERIMENTAL
Intervention: MWR only
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: MWR with motivational beliefs component
Number of subjects: 109

Group type: COMPARATOR
Intervention: Business-as-usual control
Number of subjects: 109
Study: 27632867

Group type: EXPERIMENTAL
Intervention: Strength Training Program (STP) using elastic bands for 6 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Regular training (Control Group)
Number of subjects: 39
Study: 26177480

Group type: EXPERIMENTAL
Intervention: 5mg Advax adjuvant
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 10mg Advax adjuvant
Number of subjects: 25

Group type: COMPARATOR
Intervention: TIV alone
Number of subjects: 25
Study: 23572466

Group type: EXPERIMENTAL
Intervention: Very low dose naltrexone (VLNTX) added to methadone taper
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Combination of VLNTX and clonidine
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: In-treatment smokers (n = 96)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Smokers not allowed to smoke (n = 45) or nonsmokers (n = 33)
Number of subjects: 174
Study: 21241167

Group type: EXPERIMENTAL
Intervention: New sanitary pad with a non-woven specially-shaped surface top sheet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional sanitary pad with a perforated film top sheet
Number of subjects: 21
Study: 19597420

Group type: EXPERIMENTAL
Intervention: Early administration of rhG‐CSF (4th day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Late administration of rhG‐CSF (7th day)
Number of subjects: 48
Study: 17368530

Group type: EXPERIMENTAL
Intervention: Homeopathic care (HC: individual homeopathic consultations with any homeopathic medicine in any potency being prescribed)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Self-prescribed homeopathic medicine (SPH) in C-30 administered twice weekly for 12 weeks
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Homeopathic care (HC)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Self-prescribed homeopathic medicine (SPH)
Number of subjects: 208
Study: 15353916

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) administered subcutaneously in a fixed daily dose
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional oral anticoagulant therapy (OAT)
Number of subjects: 38
Study: 11150937

Group type: EXPERIMENTAL
Intervention: Male bodybuilders
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Men with eating disorders
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control men
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Bodybuilders and men with eating disorders
Number of subjects: 88
Study: 9245865

Group type: EXPERIMENTAL
Intervention: DIEP flap
Number of subjects: 18

Group type: COMPARATOR
Intervention: TRAM flap
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 8490638

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group psychotherapy with emphasis on abstinence (high and low)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group psychotherapy with treatment intensity (high and low)
Number of subjects: 143
Study: 3318194

Group type: EXPERIMENTAL
Intervention: Chamomile extract
Number of subjects: 14
Study: 30234480

Group type: EXPERIMENTAL
Intervention: Standing frames
Number of subjects: 585
Study: 26559192

Group type: EXPERIMENTAL
Intervention: Soft wrap and buddy taping (SW)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Reduction and cast (RC)
Number of subjects: 68
Study: 24888929

Group type: EXPERIMENTAL
Intervention: Early oral feeding (liquid diets commenced 2 hours after surgery)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Delayed oral feeding (liquid diets commenced 8 hours after surgery)
Number of subjects: 140
Study: 22734372

Group type: EXPERIMENTAL
Intervention: Muscle-tension-balance acupuncture (group A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional acupuncture (group B)
Number of subjects: 70
Study: 20721460

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Local anesthesia plus sedation
Number of subjects: 50
Study: 18509207

Group type: EXPERIMENTAL
Intervention: Dual-wave (DW) bolus (50:50% over 2 h) before low-GI meals
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard bolus (100%) before low-GI meals
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-GI meals (regardless of bolus type)
Number of subjects: 20
Study: 16029698

Group type: EXPERIMENTAL
Intervention: 30-second application of sodium hydroxide
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 1-minute application of sodium hydroxide
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 2-minute application of sodium hydroxide
Number of subjects: 66
Study: 12217455

Group type: EXPERIMENTAL
Intervention: Low-dose alcohol
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: High-dose alcohol
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control
Number of subjects: 132
Study: 10614903

Group type: EXPERIMENTAL
Intervention: Bifluorid 12 (6% F)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Duraphat (2.26% F)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fluor Protector (0.1% F)
Number of subjects: 8
Study: 7863716

Group type: EXPERIMENTAL
Intervention: Prostacyclin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 10
Study: 1774568

Group type: EXPERIMENTAL
Intervention: Low-dose warfarin (LDW)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Sequential compression devices (SCD)
Number of subjects: 95
Study: 6124654

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 20 mg clorazepate dipotassium (CZP)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Oral administration of 20 mg clorazepate dipotassium (CZP)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of 20 mg clorazepate dipotassium (CZP)
Number of subjects: 17
Study: 30721093

Group type: EXPERIMENTAL
Intervention: Patterned electrical neuromuscular stimulation (PENS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham treatments
Number of subjects: 21
Study: 27606700

Group type: EXPERIMENTAL
Intervention: Web- and text messaging-based intervention over 3 months
Number of subjects: 1041

Group type: COMPARATOR
Intervention: Assessment only (Control)
Number of subjects: 1041
Study: 24279691

Group type: EXPERIMENTAL
Intervention: Diclofenac HPβCD SC
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Diclofenac HPβCD IM
Number of subjects: 325

Group type: COMPARATOR
Intervention: Voltaren® IM
Number of subjects: 325
Study: 24680796

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg daily for 8 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo daily for 8 weeks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sildenafil during open-label use for an additional 8 weeks
Number of subjects: 13
Study: 22775125

Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR) training aimed at decreasing emotional response to shock and conditioned stimuli.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no CR training).
Number of subjects: 0
Study: 19608808

Group type: EXPERIMENTAL
Intervention: Desflurane 3%-8%
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sevoflurane 1%-3%
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study: 17379748

Group type: COMPARATOR
Intervention: Sedentary bed rest (Control, n = 8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise training (n = 8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Protein and BCAA supplementation (n = 8)
Number of subjects: 24
Study: 15064594

Group type: EXPERIMENTAL
Intervention: Tai Chi practitioners
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Golfers
Number of subjects: 47

Group type: COMPARATOR
Intervention: Elderly control subjects
Number of subjects: 47
Study: 11707048

Group type: EXPERIMENTAL
Intervention: Optimized AV interval with rate adaptive AV interval shortening (optimized/R)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fixed AV interval = 150 ms with rate adaptation (150/R)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fixed AV interval = 150 ms without rate adaptation (150/Fixed)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Least-favorable AV intervals
Number of subjects: 14
Study: 9924274

Group type: EXPERIMENTAL
Intervention: Moderately-fatty breakfast (25.7 g fat; M)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low-fat high-carbohydrate breakfast (5.5 g fat; L)
Number of subjects: 24
Study: 8036679

Group type: EXPERIMENTAL
Intervention: Mefloquine (15 mg/kg) plus artesunate (10 mg/kg)
Number of subjects: 552

Group type: COMPARATOR
Intervention: High dose mefloquine (25 mg/kg)
Number of subjects: 552
Study: 2847464

Group type: EXPERIMENTAL
Intervention: 2,500 IU Logiparin
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 50 IU per kg Logiparin
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 3,500 IU Logiparin
Number of subjects: 51
Study: 29676968

Group type: EXPERIMENTAL
Intervention: Low-dose milk (120 mg/100 mL calcium, vitamin D3 30 UI/100 mL)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Group A: milk (180 mg/100 mL calcium, 120 UI/100 mL vitamin D)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Group B: milk (180 mg/100 mL calcium, 120 UI/100 mL vitamin D) and FOS (5 g/L)
Number of subjects: 500
Study: 27380030

Group type: EXPERIMENTAL
Intervention: 1000 mg of TAU
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 11
Study: 24530765

Group type: EXPERIMENTAL
Intervention: Weight gain during infancy (from birth to 18 months of age)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Birth weight
Number of subjects: 379
Study: 23312049

Group type: EXPERIMENTAL
Intervention: Combination therapy (rosuvastatin + fenofibric acid)
Number of subjects: 2066
Study: 20107154

Group type: EXPERIMENTAL
Intervention: LAL 2000 trial
Number of subjects: 46

Group type: COMPARATOR
Intervention: 0496 study
Number of subjects: 46
Study: 18756744

Group type: EXPERIMENTAL
Intervention: Free-load bicycle exercise (FBE)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Traditional therapy only
Number of subjects: 185
Study: 17086009

Group type: EXPERIMENTAL
Intervention: Impedance cardiography (ICG) care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 14506629

Group type: EXPERIMENTAL
Intervention: Troglitazone (200 mg/d)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 10641085

Group type: EXPERIMENTAL
Intervention: Trusopt + Xalatan (dorzolamide + latanoprost)
Number of subjects: 79
Study: 8767437

Group type: EXPERIMENTAL
Intervention: Sleeping with the bed-head raised (15 cm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Horizontal bed-head position
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg twice a day) for group 3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisapride (30 mg) for group 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No drug therapy for group 1
Number of subjects: 0
Study: 1717789

Group type: EXPERIMENTAL
Intervention: Beta-blockade
Number of subjects: 66

Group type: COMPARATOR
Intervention: Independent type As
Number of subjects: 66

Group type: COMPARATOR
Intervention: Dependent type As
Number of subjects: 66
Study: 7069684

Group type: EXPERIMENTAL
Intervention: Access to a clinical psychologist
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (no access to clinical psychologist)
Number of subjects: 239
Study: 30266309

Group type: EXPERIMENTAL
Intervention: Androgen Deprivation Therapy (ADT) with External Beam Radiation Therapy (EBRT)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Androgen Deprivation Therapy (ADT) alone
Number of subjects: 432
Study: 29742190

Group type: EXPERIMENTAL
Intervention: Cream-to-powder product
Number of subjects: 52
Study: 27254283

Group type: EXPERIMENTAL
Intervention: Aprepitant, granisetron, and dexamethasone (AGD)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Palonosetron and dexamethasone (PD)
Number of subjects: 84
Study: 24654454

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) for 12 weeks followed by endometrial curettage
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) treatment
Number of subjects: 10
Study: 22513154

Group type: EXPERIMENTAL
Intervention: E-learning resource focusing on pain assessment
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: E-learning resource focusing on pharmacological management
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard non-intervention group (n=164)
Number of subjects: 42
Study: 20678687

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) tablet of glimepiride/metformin 2/500 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Separate tablets of glimepiride 2 mg + metformin 500 mg
Number of subjects: 32
Study: 17723148

Group type: EXPERIMENTAL
Intervention: Early intervention service consisting of consultations with a specialised nurse for the patient and their caregiver during the first three months after cardiac arrest.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early intervention service
Number of subjects: 0
Study: 16027086

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no cerebral injury)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cerebral trauma patients
Number of subjects: 40
Study: 12473010

Group type: EXPERIMENTAL
Intervention: Registered Nurse (RN) turnover
Number of subjects: 2015

Group type: EXPERIMENTAL
Intervention: Facility characteristics (e.g., Medicare recipients, staffing levels, environmental quality)
Number of subjects: 2015

Group type: EXPERIMENTAL
Intervention: Facility characteristics (e.g., for-profit ownership, chain affiliation)
Number of subjects: 2015

Group type: COMPARATOR
Intervention: Adjustment for resident characteristics (sex, age, race, education, marital status, morbid diagnoses, functional status)
Number of subjects: 2015

Group type: EXPERIMENTAL
Intervention: Infection
Number of subjects: 2015

Group type: EXPERIMENTAL
Intervention: Hospitalization for infection
Number of subjects: 2015
Study: 9627588

Group type: EXPERIMENTAL
Intervention: Family income (low vs affluent)
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Neighborhood income (poor/middle-affluent)
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Neighborhood income (middle-income)
Number of subjects: 619
Study: 8552817

Group type: EXPERIMENTAL
Intervention: CT examination in ARDS patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: CT examination in normal subjects (control group)
Number of subjects: 14
Study: 2298963

Group type: EXPERIMENTAL
Intervention: Plasmapheresis therapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Corticosteroids and immunosuppressive drugs alone (Control)
Number of subjects: 11
Study: 80682

Group type: EXPERIMENTAL
Intervention: Prednisolone (60 mg daily for one week, 40 mg daily for four days, and then 30 mg daily for three days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no steroid treatment)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 30513485

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 27374276

Group type: EXPERIMENTAL
Intervention: Synthetic MK-7 (180 µg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fermentation-derived MK-7 (90 µg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Synthetic MK-7 (45 µg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Synthetic MK-7 (90 µg)
Number of subjects: 20
Study: 25686683

Group type: EXPERIMENTAL
Intervention: 36 months of isoniazid preventive therapy (36IPT)
Number of subjects: 1995

Group type: COMPARATOR
Intervention: 6 months of isoniazid preventive therapy (6IPT)
Number of subjects: 1995

Group type: EXPERIMENTAL
Intervention: 36IPT
Number of subjects: 1995

Group type: COMPARATOR
Intervention: 6IPT
Number of subjects: 1995

Group type: EXPERIMENTAL
Intervention: 36IPT restricted to TST-positive participants
Number of subjects: 1995

Group type: EXPERIMENTAL
Intervention: ART use
Number of subjects: 1995
Study: 23073646

Group type: EXPERIMENTAL
Intervention: Online pre-screening survey
Number of subjects: 322

Group type: COMPARATOR
Intervention: Phone screening
Number of subjects: 322
Study: 21536199

Group type: EXPERIMENTAL
Intervention: Mandibular advancement splint (MAS) therapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conservative therapy (control group)
Number of subjects: 75
Study: 19711749

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16756421

Group type: EXPERIMENTAL
Intervention: Monetary payments contingent on demonstrating recent abstinence during the intervention week
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High‐reinforcer magnitude condition
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Low‐reinforcer magnitude condition
Number of subjects: 88

Group type: COMPARATOR
Intervention: Noncontingent monetary payments during baseline weeks
Number of subjects: 88
Study: 15614029

Group type: EXPERIMENTAL
Intervention: Isoproterenol (8 mug/kg per min)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (dextrose 5%)
Number of subjects: 41
Study: 11391278

Group type: EXPERIMENTAL
Intervention: N-duopropenide alcohol solution (NDP)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Handwashing with nonantiseptic soap
Number of subjects: 69
Study: 9014908

Group type: EXPERIMENTAL
Intervention: Plasma Exchange (PE) - five 50 mL/kg exchanges over 8-13 days
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Intravenous Immunoglobulin (IVIg) - Sandoglobulin, 0.4 g/kg daily for 5 days
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Combined treatment (PE followed by IVIg)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Plasma Exchange (PE)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Intravenous Immunoglobulin (IVIg)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Combined treatment (PE + IVIg)
Number of subjects: 379
Study: 8375422

Group type: EXPERIMENTAL
Intervention: Saruplase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 0
Study: 3720724

Group type: COMPARATOR
Intervention: Carrying 0% of body mass in an external frame backpack
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Carrying 20% of body mass in an external frame backpack
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Carrying 40% of body mass in an external frame backpack
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Walking at 0.75 stature per second
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Walking at 0.95 stature per second
Number of subjects: 10
Study: 30504456

Group type: EXPERIMENTAL
Intervention: Modified Valsalva manoeuvre (VM)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Valsalva Assist Device (VAD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Supine Valsalva manoeuvre (VM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Manometer
Number of subjects: 75
Study: 27659116

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (SCP, n=8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Biofeedback control training (electromyogram feedback, n=8)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Successful learners (n=9)
Number of subjects: 16
Study: 26894628

Group type: EXPERIMENTAL
Intervention: EWA‐LOR
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional LOR
Number of subjects: 100
Study: 25494343

Group type: EXPERIMENTAL
Intervention: Vocational program
Number of subjects: 306

Group type: COMPARATOR
Intervention: Common cardiac rehabilitation
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Post-treatment proposals participation
Number of subjects: 306
Study: 21850019

Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20460063

Group type: EXPERIMENTAL
Intervention: Gastrocnemius recession surgery
Number of subjects: 4

Group type: COMPARATOR
Intervention: Matched control subjects
Number of subjects: 4
Study: 18669426

Group type: EXPERIMENTAL
Intervention: Intravenous bolus of 2.5 mg of cyclosporine per kilogram of body weight
Number of subjects: 58

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 58
Study: 16320283

Group type: EXPERIMENTAL
Intervention: Bayesian hierarchical as-treated model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed effects models
Number of subjects: 0
Study: 12743240

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227